Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Nobuto Fukuda, Hideaki Tanaka, Yohei Tominaga et al. · Journal of Clinical Investigation · 1993 · 599 citations · Full text

Medicine, Endocrinology, Nephrology +11

Serial Evaluation of Parathyroid Size by Ultrasonography Is Another Useful Marker for the Long-Term Prognosis of Calcitriol Pulse Therapy in Chronic Dialysis Patients

Masafumi Fukagawa, Masafumi Kitaoka, Hung Yi et al. · ˜The œNephron journals/Nephron journals · 2008 · 170 citations

Medicine, Endocrinology, Nephrology +16

Parathyroid function in persistent hyperparathyroidism: Relationship to gland size

David A. McCarron, Richard S. Muther, Barbara Lenfesty et al. · Kidney International · 1982 · 106 citations · Full text

Medicine, Endocrinology, Physiology +13

The ‘Oral 1,25-Dihydroxyvitamin D ₃ Pulse Therapy’ in Hemodialysis Patients with Severe Secondary Hyperparathyroidism

Yusuke Tsukamoto, Masanori Nomura, Yuuichiro Takahashi et al. · ˜The œNephron journals/Nephron journals · 2008 · 104 citations

Medicine, Endocrinology, Nephrology +16